ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 86 filers reported holding ADURO BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,000 | -32.6% | 29,154 | -3.3% | 0.00% | – |
| Q2 2019 | $46,000 | -66.2% | 30,161 | -11.4% | 0.00% | -100.0% |
| Q1 2019 | $136,000 | +52.8% | 34,053 | +1.1% | 0.00% | 0.0% |
| Q4 2018 | $89,000 | -69.8% | 33,676 | -16.0% | 0.00% | -50.0% |
| Q3 2018 | $295,000 | +1.4% | 40,090 | -3.5% | 0.00% | 0.0% |
| Q2 2018 | $291,000 | -24.6% | 41,537 | +0.1% | 0.00% | -33.3% |
| Q1 2018 | $386,000 | +6.6% | 41,496 | -14.1% | 0.00% | 0.0% |
| Q4 2017 | $362,000 | -24.4% | 48,329 | +7.4% | 0.00% | -25.0% |
| Q3 2017 | $479,000 | +6.4% | 45,009 | +14.0% | 0.00% | 0.0% |
| Q2 2017 | $450,000 | +4.9% | 39,483 | -1.1% | 0.00% | 0.0% |
| Q1 2017 | $429,000 | -24.9% | 39,941 | -20.2% | 0.00% | -33.3% |
| Q4 2016 | $571,000 | +3.6% | 50,081 | +13.0% | 0.01% | -25.0% |
| Q3 2016 | $551,000 | -7.1% | 44,338 | -15.4% | 0.01% | 0.0% |
| Q2 2016 | $593,000 | -3.3% | 52,433 | +9.6% | 0.01% | 0.0% |
| Q1 2016 | $613,000 | -57.5% | 47,819 | -6.8% | 0.01% | -52.9% |
| Q4 2015 | $1,443,000 | – | 51,296 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 745,886 | $8,503,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 915,134 | $10,433,000 | 0.34% |
| Rock Springs Capital Management LP | 415,000 | $4,731,000 | 0.32% |
| CLOUGH CAPITAL PARTNERS L P | 326,400 | $3,721,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $608,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 36,200 | $413,000 | 0.10% |
| Vident Investment Advisory, LLC | 65,874 | $751,000 | 0.09% |
| Virtus ETF Advisers LLC | 23,109 | $263,000 | 0.08% |
| Foundry Partners, LLC | 77,452 | $883,000 | 0.04% |
| Artal Group S.A. | 100,000 | $1,140,000 | 0.02% |